α- and γ-mangostin cause shape changes, inhibit aggregation and induce cytolysis of rat platelets

Chemico-Biological Interactions

Volumn 240, Issue , 2015, Pages 240-248

  Liu, Yingqiu ^a   Park, Jung Min ^a   Chang, Kyung Hwa ^a   Chin, Young Won ^a   Lee, Moo Yeol ^a  

^a Dongguk University   (South Korea)

Author keywords

Aggregation; Cytotoxicity; Platelets; Shape change; Mangostin; Mangostin

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ADENOSINE DIPHOSPHATE; ALPHA MANGOSTIN; CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GAMMA MANGOSTIN; LACTATE DEHYDROGENASE; MYOSIN LIGHT CHAIN; RHO KINASE; THROMBIN; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE; GAMMA-MANGOSTIN; MANGOSTIN; PROTEIN KINASE INHIBITOR;

ACTIN FILAMENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIPLATELET ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL SHAPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; DRUG CYTOTOXICITY; DRUG MECHANISM; ENZYME INHIBITION; EXTRACELLULAR CALCIUM; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SUPERNATANT; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; ANIMAL; CELL AGGREGATION; CHEMISTRY; CLASSIFICATION; DRUG EFFECTS; MALE; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; CELL AGGREGATION; CELL SHAPE; MALE; PROTEIN KINASE INHIBITORS; RATS; XANTHONES;

EID: 84941273201     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2015.08.021     Document Type: Article

References (51)

1. J. Pedraza-Chaverri, N. Cardenas-Rodriguez, M. Orozco-Ibarra, and J.M. Perez-Rojas Medicinal properties of mangosteen (Garcinia mangostana) Food Chem. Toxicol. 46 2008 3227 3239
2. M.E. Mohamed, and R.F. Frye Effects of herbal supplements on drug glucuronidation. Review of clinical, animal, and in vitro studies Planta Med. 77 2011 311 321
3. Y.W. Chin, and A.D. Kinghorn Structural characterization, biological effects, and synthetic studies on xanthones from Mangosteen (Garcinia mangostana), a popular botanical dietary supplement Mini Rev. Org. Chem. 5 2008 355 364
4. H.A. Jung, B.N. Su, W.J. Keller, R.G. Mehta, and A.D. Kinghorn Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen) J. Agric. Food Chem. 54 2006 2077 2082
5. S. Suksamrarn, N. Suwannapoch, P. Ratananukul, N. Aroonlerk, and A. Suksamrarn Xanthones from the green fruit hulls of Garcinia mangostana J. Nat. Prod. 65 2002 761 763
6. D. Obolskiy, I. Pischel, N. Siriwatanametanon, and M. Heinrich Garcinia mangostana L.: a phytochemical and pharmacological review Phytother. Res. 23 2009 1047 1065
7. E.L. Bearer, J.M. Prakash, and Z. Li Actin dynamics in platelets Int. Rev. Cytol. 217 2002 137 182
8. J.H. Hartwig, K. Barkalow, A. Azim, and J. Italiano The elegant platelet: signals controlling actin assembly Thromb. Haemost. 82 1999 392 398
9. A. Aburima, K.S. Wraith, Z. Raslan, R. Law, S. Magwenzi, and K.M. Naseem cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway Blood 122 2013 3533 3545
10. B.Z. Paul, J.L. Daniel, and S.P. Kunapuli Platelet shape change is mediated by both calcium-dependent and -independent signaling pathways. Role of p160 Rho-associated coiled-coil-containing protein kinase in platelet shape change J. Biol. Chem. 274 1999 28293 28300
11. P.F. Bray Platelet hyperreactivity: predictive and intrinsic properties Hematol. Oncol. Clin. North. Am. 21 2007 633 645
12. Y.M. Shen, and E.P. Frenkel Acquired platelet dysfunction Hematol. Oncol. Clin. North. Am. 21 2007 647 661
13. A.D. Michelson Antiplatelet therapies for the treatment of cardiovascular disease Nat. Rev. Drug Discov. 9 2010 154 169
14. K.W. Lin, S.C. Fang, C.F. Hung, B.J. Shieh, S.C. Yang, C.M. Teng, and C.N. Lin Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives Arch. Pharm. Weinh. 342 2009 19 26
15. Y.W. Chin, H.A. Jung, H. Chai, W.J. Keller, and A.D. Kinghorn Xanthones with quinone reductase-inducing activity from the fruits of Garcinia mangostana (Mangosteen) Phytochemistry 69 2008 754 758
16. C. Fan, and J. Su Antioxidative mechanism of isolated components from methanol extract of fruit hulls of G. Mangostana L. J. Chin. Agr. Chem. Soc. 35 1997 540 551
17. A. Sobotkova, L. Masova-Chrastinova, J. Suttnar, J. Stikarova, P. Majek, Z. Reicheltova, R. Kotlin, J.W. Weisel, M. Maly, and J.E. Dyr Antioxidants change platelet responses to various stimulating events Free Radic. Biol. Med. 47 2009 1707 1714
18. D.J. Jiang, Z. Dai, and Y.J. Li Pharmacological effects of xanthones as cardiovascular protective agents Cardiovasc. Drug Rev. 22 2004 91 102
19. F. Violi, and P. Pignatelli Platelet oxidative stress and thrombosis Thromb. Res. 129 2012 378 381
20. Y. Curin, and R. Andriantsitohaina Polyphenols as potential therapeutical agents against cardiovascular diseases Pharmacol. Rep. 57 Suppl. 2005 97 107
21. K. Nakatani, N. Nakahata, T. Arakawa, H. Yasuda, and Y. Ohizumi Inhibition of cyclooxygenase and prostaglandin E2 synthesis by γ-mangostin, a xanthone derivative in mangosteen, in C6 rat glioma cells Biochem. Pharmacol. 63 2002 73 79
22. J.D. Deschamps, J.T. Gautschi, S. Whitman, T.A. Johnson, N.C. Gassner, P. Crews, and T.R. Holman Discovery of platelet-type 12-human lipoxygenase selective inhibitors by high-throughput screening of structurally diverse libraries Bioorg. Med. Chem. 15 2007 6900 6908
23. A.C. Svensson Holm, M. Grenegard, K. Ollinger, and E.G. Lindstrom Inhibition of 12-lipoxygenase reduces platelet activation and prevents their mitogenic function Platelets 25 2014 111 117
24. J. Yeung, and M. Holinstat 12-lipoxygenase: a potential target for novel anti-platelet therapeutics Cardiovasc. Hematol. Agents Med. Chem. 9 2011 154 164
25. N. Chairungsrilerd, K.I. Furukawa, T. Ohta, S. Nozoe, and Y. Ohizumi γ-Mangostin, a novel type of 5-hydroxytryptamine 2A receptor antagonist Naunyn Schmiedeb. Arch. Pharmacol. 357 1998 25 31
26. N. Chairungsrilerd, K. Furukawa, T. Ohta, S. Nozoe, and Y. Ohizumi Histaminergic and serotonergic receptor blocking substances from the medicinal plant Garcinia mangostana Planta Med. 62 1996 471 472
27. R. Nosál', V. Jančinová, and E. Danihelova The H1-histamine antagonist dithiaden inhibits human platelet function in vitro Platelets 8 1997 175 180
28. E. Masini, M.G. Di Bello, S. Raspanti, J.F. Ndisang, R. Baronti, P. Cappugi, and P.F. Mannaioni The role of histamine in platelet aggregation by physiological and immunological stimuli Inflamm. Res. 47 1998 211 220
29. G.H. Quan, S.R. Oh, J.H. Kim, H.K. Lee, A.D. Kinghorn, and Y.W. Chin Xanthone constituents of the fruits of Garcinia mangostana with anticomplement activity Phytother. Res. 24 2010 1575 1577
30. Y.H. Choi, S.Y. Han, Y.J. Kim, Y.M. Kim, and Y.W. Chin Absorption, tissue distribution, tissue metabolism and safety of a-mangostin in mangosteen extract using mouse models Food. Chem. Toxicol. 66 2014 140 146
31. Y. Liu, S.J. Oh, K.H. Chang, Y.G. Kim, and M.Y. Lee Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole Biochem. Pharmacol. 86 2013 914 925
32. P. Gunnarsson, L. Levander, P. Pahlsson, and M. Grenegard α1-acid glycoprotein (AGP)-induced platelet shape change involves the Rho/Rho kinase signalling pathway Thromb. Haemost. 102 2009 694 703
33. S.J. Oh, H.K. Han, K.W. Kang, Y.J. Lee, and M.Y. Lee Menadione serves as a substrate for P-glycoprotein: implication in chemosensitizing activity Arch. Pharm. Res. 36 2013 509 516
34. K.A. Kim, J.Y. Lee, K.S. Park, M.J. Kim, and J.H. Chung Mechanism of menadione-induced cytotoxicity in rat platelets Toxicol. Appl. Pharmacol. 138 1996 12 19
35. T.M. Getz, C.A. Dangelmaier, J. Jin, J.L. Daniel, and S.P. Kunapuli Differential phosphorylation of myosin light chain (Thr)18 and (Ser)19 and functional implications in platelets J. Thromb. Haemost. 8 2010 2283 2293
36. Y. Suzuki, M. Yamamoto, H. Wada, M. Ito, T. Nakano, Y. Sasaki, S. Narumiya, H. Shiku, and M. Nishikawa Agonist-induced regulation of myosin phosphatase activity in human platelets through activation of Rho-kinase Blood 93 1999 3408 3417
37. G.E. Kass, and S. Orrenius Calcium signaling and cytotoxicity Environ. Health Perspect. 107 Suppl. 1 1999 25 35
38. L. Li, A.R. Han, A.D. Kinghorn, R.F. Frye, H. Derendorf, and V. Butterweck Pharmacokinetic properties of pure xanthones in comparison to a mangosteen fruit extract in rats Planta Med. 79 2013 646 653
39. A. Ramaiya, G. Li, S.M. Petiwala, and J.J. Johnson Single dose oral pharmacokinetic profile of α-mangostin in mice Curr. Drug Targets 13 2012 1698 1704
40. S.M. Petiwala, G. Li, A. Ramaiya, A. Kumar, R.K. Gill, S. Saksena, and J.J. Johnson Pharmacokinetic characterization of mangosteen (Garcinia mangostana) fruit extract standardized to α-mangostin in C57BL/6 mice Nutr. Res. 34 2014 336 345
41. F. Michal, and M. Motamed Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline Br. J. Pharmacol. 56 1976 209 218
42. J. Connor, L.M. Currie, H. Allan, and S.A. Livesey Recovery of in vitro functional activity of platelet concentrates stored at 4 °C and treated with second-messenger effectors Transfusion 36 1996 691 698
43. J. Zahavi, M. Zahavi, E. Firsteter, B. Frish, R. Turleanu, and R. Rachmani An abnormal pattern of multiple platelet function abnormalities and increased thromboxane generation in patients with primary thrombocytosis and thrombotic complications Eur. J. Haematol. 47 1991 326 332
44. Y.S. Won, J.H. Lee, S.J. Kwon, J.Y. Kim, K.H. Park, M.K. Lee, and K.I. Seo α-Mangostin-induced apoptosis is mediated by estrogen receptor alpha in human breast cancer cells Food Chem. Toxicol. 66 2014 158 165
45. J.J. Johnson, S.M. Petiwala, D.N. Syed, J.T. Rasmussen, V.M. Adhami, I.A. Siddiqui, A.M. Kohl, and H. Mukhtar α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth Carcinogenesis 33 2012 413 419
46. B.B. Hafeez, A. Mustafa, J.W. Fischer, A. Singh, W. Zhong, M.O. Shekhani, L. Meske, T. Havighurst, K. Kim, and A.K. Verma α-Mangostin: a dietary antioxidant derived from the pericarp of Garcinia mangostana L. inhibits pancreatic tumor growth in xenograft mouse model Antioxid. Redox Signal. 21 2014 682 699
47. K. Matsumoto, Y. Akao, K. Ohguchi, T. Ito, T. Tanaka, M. Iinuma, and Y. Nozawa Xanthones induce cell-cycle arrest and apoptosis in human colon cancer DLD-1 cells Bioorg. Med. Chem. 13 2005 6064 6069
48. A. Sato, H. Fujiwara, H. Oku, K. Ishiguro, and Y. Ohizumi α-Mangostin induces Ca2+-ATPase-dependent apoptosis via mitochondrial pathway in PC12 cells J. Pharmacol. Sci. 95 2004 33 40
49. R. Benjakul, L. Kongkaneramit, N. Sarisuta, P. Moongkarndi, and C.C. Müller-Goymann Cytotoxic effect and mechanism inducing cell death of α-mangostin liposomes in various human carcinoma and normal cells Anticancer Drugs 26 2015 824 834
50. S. Suksamrarn, O. Komutiban, P. Ratananukul, N. Chimnoi, N. Lartpornmatulee, and A. Suksamrarn Cytotoxic prenylated xanthones from the young fruit of Garcinia mangostana Chem. Pharm. Bull. (Tokyo) 54 2006 301 305
51. S.B. Brown, M.C. Clarke, L. Magowan, H. Sanderson, and J. Savill Constitutive death of platelets leading to scavenger receptor-mediated phagocytosis. A caspase-independent cell clearance program J. Biol. Chem. 275 2000 5987 5996